HIV and Mycobacterium TB cause increased mortality among TB and HIV patients. The diagnosis of HIV and TB is currently done separately and as a result, treatment is delayed, particularly for TB since diagnosis has a long turnaround time. Thus, the project aims to develop a point-of-care assay for multiplex diagnosis of TB and HIV-1 co-infection in human blood using markers for active TB and HIV infection.
Position in Company
Laboratory technician
Media
Kanyane Bridgett Malatji (003).png
Topic
Development of a multiplex HIV/TB point-of-care diagnostic assay based on the microarray technology